Toronto, ON – January 16, 2026 – This afternoon, the Canadian Nuclear Isotope Council (CNIC) and the Canadian Nuclear Society (CNS) signed a historic Memorandum of Understanding (MoU) to foster a stronger, more connected nuclear ecosystem in Canada. This agreement formalizes a growing relationship between the two organizations and outlines a shared vision for collaboration, knowledge exchange, and strategic alignment across their respective networks.
For decades, the CNS has been a pillar of Canada’s nuclear community, bringing together engineers, researchers, students, and nuclear professionals to share technical knowledge and strengthen the country’s nuclear science capabilities. Through its conferences, publications, and public education initiatives, the CNS has helped foster a culture of innovation and nuclear safety.
In parallel, the CNIC has emerged as the national voice for Canada’s isotope sector since its founding in 2018. The CNIC has played a key role in repositioning the isotope sector as a strategic national asset, essential to the growth of several major industries. Through its national advocacy, partnerships, and cross-industry coordination, the CNIC has led efforts to double domestic isotope production by 2030 and expand access to radiopharmaceuticals across the country.
As Canada advances next-generation reactor designs, expands its isotope infrastructure, and accelerates the use of isotopes in medicine, the scientific expertise championed by CNS is becoming integral to the CNIC’s broader policy, advocacy, and healthcare goals.
The MoU signed today by the CNIC and the CNS reflects the growing convergence of the organizations’ roles and identifies new opportunities to work together. The agreement will enable expanded communication, coordination of events and initiatives, and friendly exchanges between each organization’s membership.
“This agreement reflects our shared commitment to shaping a future where the nuclear energy and nuclear medicine sectors are not siloed, but work collaboratively to deliver greater impact,” said Melody Greaves, Executive Director of the CNIC. “This MoU between the CNIC and the CNS creates a bridge between technical expertise and applied innovation which is essential to ensuring Canadians benefit from the full promise of nuclear technology”
“We are very excited to formalize the relationship between the CNS and the CNIC. Canada has long been a leader in both nuclear power and medical isotope production and use, and the two industries have developed along side each other,” said Derek Mullin, President of the CNS. “With both industries in growth phases that will boost Canada into a higher league on the world stage it’s important that we all work together to maximise the opportunity for the nation”.
This partnership reinforces a shared understanding: building Canada’s nuclear and medical isotope future depends on deliberate collaboration between the communities that power them.
To learn more about the CNS, visit cns-snc.ca.
About the Canadian Nuclear Isotope Council
The Canadian Nuclear Isotope Council (CNIC) is an independent, not-for-profit advocacy and member services organization. The CNIC supports over 115 members from across science, academia, healthcare, and nuclear-sector organizations dedicated to maintaining Canada’s position as a global leader in the production of life-saving isotopes. The CNIC raises awareness and advocates for long-term policies that support health-care innovation and will save countless lives for decades to come.
To learn more about the CNIC, visit www.CanadianIsotopes.ca and follow us on Facebook, Twitter, and LinkedIn, or please contact:
Evan Cameron
Manager, Public Affairs and Communications
Canadian Nuclear Isotope Council
evan.cameron@canadianisotopes.ca